Background:The AMES (age, distant metastasis, tumor extent, and size), AGES (age, tumor size, histologic grade, tumor extent, distant metastasis), and MACIS (distant metastasis, age, completeness of primary tumor resection, local invasion, and tumor size) prognostic systems for welldifferentiated thyroid carcinoma (WDTC) are well known. The development of disease recurrence is associated with a poor outcome; however, the prognostic importance of multiple treatment failures has not been clearly reported.Objectives: To identify patient, tumor, and treatment factors that may be associated with the development of multiple recurrences in WDTC.Design and Setting: All patients treated for residual or recurrent WDTC were retrospectively identified from the thyroid cancer database at the Department of Otolaryngology-Head and Neck Surgery, Mount Sinai Hospital, Toronto, Ontario (1963-2000. Data on relevant patient, tumor, and treatment factors were collected. Main Outcome Measures: Patient, tumor, and treatment factors predicting the development of multiple treatment failures, disease-specific survival, and overall survival.Results: A total of 574 patients (115 male, 459 female; median age, 42 years [range, 9-92 years]) were identified, whose final histopathologic diagnosis was papillary carcinoma in 468, follicular carcinoma in 76, and ORIGINAL ARTICLE